Viola Zhu
Hematology & Oncology · Worcester, MANPI 1588814404
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $118,258 of the $163,744 with a category attached, or 72.2%. 5 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 57.1% of the total. Reporting peaked in 2019 at $99,715 and has fallen 99.9% since, to $104 in 2023. Among hematology & oncology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $1279.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$94K
- AstraZeneca$54K
- Genentech USA, Inc.$8K
- Blueprint Medicines Corporation$6K
- Beigene, Ltd.$2K
Across 78 payments — averaging $16,974 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$552K
- Blueprint Medicines Corporation$340K
- Takeda Pharmaceuticals U.S.A., Inc.$209K
- Merck$189K
- EMD Serono, Inc.$31K
- F. Hoffmann-la Roche AG$2K
- plus $1K from 3 others
What the payments were for
- Consulting fees$30,69819%
- Speaking & faculty fees$118,25872%
- Travel & lodging$12,5888%
- Food & beverage$2,1921%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $93,510 |
| AstraZeneca | 57 | $54,290 |
| Genentech USA, Inc. | 10 | $8,069 |
| Blueprint Medicines Corporation | 6 | $6,088 |
| Beigene, Ltd. | 1 | $1,788 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$163,744 in reported general payments places this provider in the 90th percentile of 374 hematology & oncology providers in Massachusetts.
Other hematology & oncology in Worcester
- Tariq MughalWorcester$292K
- David ScaddenBoston$2.6M
- Sara TolaneyBoston$799K
- Matthew DavidsBoston$693K
- Stephanie BernsteinWinchester$622K
- Julio HajdenbergBoston$583K
- Paul RichardsonBoston$523K
- Seth WanderBoston$464K
- Corey CutlerBoston$454K
- Hanny Al-SamkariBoston$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.